DETAILED NOTES ON CHLORPROMAZINE

Thus, although we display that mix therapies involving CX-5461 have promising anti-tumor action in vivo in neuroblastoma, our identification of TOP2B as the main goal of CX-5461 implies unanticipated safety problems that should be examined in ongoing stage II scientific trials in Grownup patients just before pursuing scientific scientific tests in